| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| « Jul | ||||||
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 | |||
Pharmacy Links
- Canada Online Pharmacy
- Cheap Viagra Online
- Mexican Online Pharmacy
- Online pharmacy – generics without a prescription
Tags
Categories
- Allergies
- Anti Depressants-Sleeping Aid
- Anti-Infectives
- Anti-Psychotics
- Arthritis
- Cancer
- Cardio & Blood-Cholesterol
- Diabetes
- Epilepsy
- Gastrointestinal
- General health
- Healthy bones Osteoporosis Rheumatic
- Herbal
- HIV
- Hormonal
- Men's Health-Erectile Dysfunction
- Skin Care
- Weight Loss
- Women's Health
This is one of the most common forms of arthritis. Its incidence varies among racial and ethnic groups, however. Approximately 1 in 100 Caucasians is diagnosed each year. It affects Asians at a much lower rate. Its incidence among the Japanese is roughly 2 to 4 out of every 10,000 people. Some groups of Native Americans, notably the Yakima, Pima, and Chippewa, have the highest prevalence rates at around 5 percent. Though the incidence of rheumatoid arthritis varies among races, its occurrence does not seem to correlate with where one lives.
Women are affected by rheumatoid arthritis three to four times more commonly than men. A major American study conducted in 1964 indicated that the prevalence was 3.8 percent among women and 1.3 percent among men.
Rheumatoid arthritis is one of the most common forms of arthritis. No one knows exactly when this affliction came into being, especially in North America. Since artifacts and skeletal remains indicate that the disease affected North American Indians several thousand years ago, the disease probably predated the arrival of the first explorers. Communicable diseases like syphilis may have been transported to this continent by European explorers, but that is not the case for rheumatoid arthritis.
*2/141/5*
I have a recent newspaper clipping before me. An Associated Press correspondent reports from a medical conference, held in October, 1966 in San Francisco:
The president of the National Arthritis Foundation, Dr. William S. Clark, says medical science will, within a relatively short time, be able to pinpoint the causes of arthritis. It could come, he said, within ten years… Discovery of the causes of arthritis will provide the key to the cure of this disease.”
That statement sums up the present stand of orthodox medicine in relation to arthritis. Medical researchers admit that they do not know what causes arthritis and, consequently, do not know how to cure it.
Biological medicine takes a much more hopeful stand on the problem of arthritis.
Although in all fairness it must be admitted that the final answers to the exact nature and the mechanics of the disease could not be pinpointed in detail in every case of arthritis, the empirical and practical experience of biological therapies and their positive results show that arthritis is caused by a metabolic disorder in the body. The distorted or disordered metabolism, in turn, is affected by health-destroying environmental factors, including faulty nutrition, overeating, emotional and physical stresses, sedentary life, etc.
The prevalent observation of practitioners is that the arthritic patient usually suffers from general deterioration of health in the form of sluggishness in the vital functions of his organs; incomplete digestion and assimilation of foods; impaired elimination of metabolic wastes and toxins from the system; a weakened nervous system and circulation; etc. These systemic disturbances affect the biochemical structure of the various tissues of the body. One of the pioneer practitioners of biological medicine in the United States, Dr. R. P. Watterson, M.D., calls the result of such a systemic disturbance a “biochemical suffocation.”
One of the most characteristic pathological changes observed in rheumatoid arthritis is the degenerative changes in collagen. The changes in collagen—the connective tissues of the body, the intercellular cement—are affected by biochemical changes brought about by metabolic disorders or nutritional deficiencies. The resultant accumulation of the fibrous tissue in the joints and the accumulation of toxic wastes and mineral deposits completes the picture of a fully developed arthritis.
The reasons for the pathological degenerative changes in the tissues leading to crippling arthritis can be found in a number of man’s environmental factors. Some of these are: allergic reactions; results of severe stress or injuries to the joints or related soft tissues; various kinds of infections; etc. However, by far the most important causative factor in arthritis is civilized man’s general deterioration of health and his diminished resistance due to faulty nutrition: overeating, malnutrition due to devitalized diet, vitamin-mineral-hormone deficiencies, etc. In addition to nutrition, other negative factors in man’s environment contribute to diminished vitality and general deterioration of his health. Sedentary life with its resultant impaired circulation and anoxia; constipation; smoking and drinking; contaminated air and water; emotional and physical stresses; lack of adequate rest—all these contribute to man’s bodily deterioration.
*10\176\2*
A STUDY ON DOSE EFFECTIVENESS AND PATIENT RESPONSE-SUMMARY
The results of this study lead to several conclusions regarding its five principal objectives:
1.) Optimum dosage levels appear to be equal for all three types of arthritis investigated: osteoarthritis, rheumatoid arthritis, and reactive psoriatic arthritis. This is evidenced by the gradual return of minor arthritis symptoms in several of those treated with only 16 or 24 capsules, and no regression in those treated with 50 capsules in two series separated by one week without treatment.
2.) Dosage level requirements appear to be equal irrespective of the severity of the subject’s condition.
3.) Initial response time for minor improvement appears to vary from two to seven days irrespective of the severity of the subject’s condition.
4.) The time for maximum attainable response appears to vary from seven to twenty-one days, resulting in 70% to 100% overall improvement. (Apart from this study, three of the most severely afflicted subjects were treated again after a five week interval, resulting in an additional 10% to 20% overall improvement.)
In addition, it was evident that for many subjects the relief of inflammation resulted in marked improvement in joint deformation.
It is important to note that the substance utilized for oral administration in this study, CMO, was not an unmodified cetylmyristoleate, but the unique form of cetylmyristoleate
(cerasomal-cis-9-cetylmyristoleate) – produced using cerasomal techniques to give it a high level of bioavailability when taken orally. Free cetylmyristoleate liquid has very low levels of bioavailabilty orally, and is best utilized only as an injectable.
This study was conducted at the San Diego Clinic, Chula Vista, California, and several additional sites following a model prepared by the San Diego Clinic.
Note: This is the first ever human clinica study conducted, and it was done using only authentic CMO. We have seen promotional literature for other products referring to our study as if it applied to their products. It does not. Any such claim is fraudulent and we do not hesitate to take legal action against such criminal trickery.
*64\142\2*